Alkim Alkali Kimya A.S. Logo

Alkim Alkali Kimya A.S.

ALKIM.IS

(3.2)
Stock Price

35,58 TRY

22.33% ROA

43.97% ROE

11.4x PER

Market Cap.

5.400.000.000,00 TRY

6.14% DER

2.57% Yield

16.78% NPM

Alkim Alkali Kimya A.S. Stock Analysis

Alkim Alkali Kimya A.S. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Alkim Alkali Kimya A.S. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (43.22%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a low debt to equity ratio (6%), which means it has a small amount of debt compared to the ownership it holds

4 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

6 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

7 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (356), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

8 PBV

The stock's high Price-to-Book Value (P/BV) ratio (4.92x) suggests it's overvalued, potentially making it an expensive investment.

9 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

10 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Alkim Alkali Kimya A.S. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Alkim Alkali Kimya A.S. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Alkim Alkali Kimya A.S. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Alkim Alkali Kimya A.S. Revenue
Year Revenue Growth
2004 311.147.419
2005 100.728.457 -208.9%
2006 119.244.540 15.53%
2007 142.463.440 16.3%
2008 147.851.194 3.64%
2009 147.908.423 0.04%
2010 162.956.649 9.23%
2011 198.701.999 17.99%
2012 210.187.609 5.46%
2013 226.926.258 7.38%
2014 246.689.713 8.01%
2015 262.136.444 5.89%
2016 300.049.516 12.64%
2017 395.256.839 24.09%
2018 589.163.482 32.91%
2019 691.440.119 14.79%
2020 754.148.916 8.32%
2021 1.096.488.544 31.22%
2022 2.796.944.467 60.8%
2023 3.040.681.864 8.02%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Alkim Alkali Kimya A.S. Research and Development Expenses
Year Research and Development Expenses Growth
2004 83.950
2005 0 0%
2006 215.720 100%
2007 197.480 -9.24%
2008 482.376 59.06%
2009 1.142.573 57.78%
2010 684.569 -66.9%
2011 573.680 -19.33%
2012 608.036 5.65%
2013 145.631 -317.52%
2014 144.599 -0.71%
2015 83.728 -72.7%
2016 88.413 5.3%
2017 96.588 8.46%
2018 602.143 83.96%
2019 115.849 -419.77%
2020 144.547 19.85%
2021 153.459 5.81%
2022 794.538 80.69%
2023 551.744 -44%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Alkim Alkali Kimya A.S. General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 6.161.292
2005 0 0%
2006 -2.142.240 100%
2007 -2.274.570 5.82%
2008 6.234.618 136.48%
2009 7.155.941 12.87%
2010 7.457.343 4.04%
2011 8.183.373 8.87%
2012 2.400.989 -240.83%
2013 2.377.848 -0.97%
2014 2.595.072 8.37%
2015 3.209.776 19.15%
2016 2.716.837 -18.14%
2017 15.655.502 82.65%
2018 5.161.693 -203.3%
2019 25.581.427 79.82%
2020 27.947.420 8.47%
2021 33.821.250 17.37%
2022 59.552.006 43.21%
2023 91.055.308 34.6%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Alkim Alkali Kimya A.S. EBITDA
Year EBITDA Growth
2004 224.680.526
2005 24.195.854 -828.59%
2006 24.858.270 2.66%
2007 35.302.000 29.58%
2008 48.883.025 27.78%
2009 41.283.008 -18.41%
2010 28.462.066 -45.05%
2011 44.518.727 36.07%
2012 34.912.461 -27.52%
2013 38.305.048 8.86%
2014 36.853.891 -3.94%
2015 44.810.107 17.76%
2016 77.455.872 42.15%
2017 91.843.536 15.67%
2018 143.751.519 36.11%
2019 189.400.724 24.1%
2020 260.603.398 27.32%
2021 375.992.789 30.69%
2022 878.463.106 57.2%
2023 876.263.300 -0.25%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Alkim Alkali Kimya A.S. Gross Profit
Year Gross Profit Growth
2004 237.173.741
2005 25.559.145 -827.94%
2006 31.107.800 17.84%
2007 38.205.340 18.58%
2008 41.475.098 7.88%
2009 42.002.490 1.26%
2010 35.988.526 -16.71%
2011 49.938.266 27.93%
2012 47.932.826 -4.18%
2013 54.836.347 12.59%
2014 68.095.832 19.47%
2015 66.604.854 -2.24%
2016 86.471.442 22.97%
2017 92.446.464 6.46%
2018 164.504.572 43.8%
2019 201.046.953 18.18%
2020 256.000.381 21.47%
2021 304.185.376 15.84%
2022 882.359.657 65.53%
2023 693.672.072 -27.2%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Alkim Alkali Kimya A.S. Net Profit
Year Net Profit Growth
2004 8.802.967
2005 7.930.893 -11%
2006 11.170.070 29%
2007 18.230.100 38.73%
2008 24.120.776 24.42%
2009 22.134.173 -8.98%
2010 13.532.853 -63.56%
2011 22.677.203 40.32%
2012 14.802.928 -53.19%
2013 16.556.238 10.59%
2014 20.519.441 19.31%
2015 30.545.452 32.82%
2016 46.915.306 34.89%
2017 63.598.382 26.23%
2018 87.102.714 26.98%
2019 131.518.069 33.77%
2020 199.189.141 33.97%
2021 248.125.334 19.72%
2022 572.307.342 56.64%
2023 542.058.296 -5.58%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Alkim Alkali Kimya A.S. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 1 0%
2019 1 0%
2020 1 100%
2021 2 0%
2022 4 66.67%
2023 4 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Alkim Alkali Kimya A.S. Free Cashflow
Year Free Cashflow Growth
2005 -1.867.724
2006 1.467.300 227.29%
2007 17.507.340 91.62%
2008 12.627.903 -38.64%
2009 36.028.518 64.95%
2010 -158.416 22842.98%
2011 -35.708.911 99.56%
2012 16.225.140 320.08%
2013 12.285.604 -32.07%
2014 32.174.112 61.82%
2015 18.611.094 -72.88%
2016 31.246.766 40.44%
2017 22.744.676 -37.38%
2018 75.976.181 70.06%
2019 121.202.616 37.31%
2020 81.806.109 -48.16%
2021 218.853.487 62.62%
2022 58.051.911 -277%
2023 284.127.155 79.57%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Alkim Alkali Kimya A.S. Operating Cashflow
Year Operating Cashflow Growth
2005 4.794.312
2006 16.049.380 70.13%
2007 25.836.900 37.88%
2008 20.146.715 -28.24%
2009 38.737.196 47.99%
2010 30.420.957 -27.34%
2011 3.781.815 -704.4%
2012 26.406.036 85.68%
2013 22.650.041 -16.58%
2014 39.155.985 42.15%
2015 26.403.168 -48.3%
2016 68.326.028 61.36%
2017 70.538.031 3.14%
2018 92.830.567 24.01%
2019 142.850.303 35.02%
2020 100.638.742 -41.94%
2021 364.966.867 72.43%
2022 173.552.668 -110.29%
2023 297.480.485 41.66%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Alkim Alkali Kimya A.S. Capital Expenditure
Year Capital Expenditure Growth
2005 6.662.036
2006 14.582.080 54.31%
2007 8.329.560 -75.06%
2008 7.518.812 -10.78%
2009 2.708.678 -177.58%
2010 30.579.373 91.14%
2011 39.490.726 22.57%
2012 10.180.896 -287.89%
2013 10.364.437 1.77%
2014 6.981.873 -48.45%
2015 7.792.074 10.4%
2016 37.079.262 78.99%
2017 47.793.355 22.42%
2018 16.854.386 -183.57%
2019 21.647.687 22.14%
2020 18.832.633 -14.95%
2021 146.113.380 87.11%
2022 115.500.757 -26.5%
2023 13.353.330 -764.96%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Alkim Alkali Kimya A.S. Equity
Year Equity Growth
2004 107.731.455
2005 90.146.995 -19.51%
2006 108.563.380 16.96%
2007 114.654.780 5.31%
2008 105.849.446 -8.32%
2009 136.188.035 22.28%
2010 138.168.602 1.43%
2011 151.935.057 9.06%
2012 158.521.414 4.15%
2013 169.168.447 6.29%
2014 178.801.808 5.39%
2015 193.633.567 7.66%
2016 221.028.360 12.39%
2017 261.761.223 15.56%
2018 348.518.341 24.89%
2019 422.153.231 17.44%
2020 541.463.249 22.03%
2021 737.094.409 26.54%
2022 1.247.542.862 40.92%
2023 1.313.833.760 5.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Alkim Alkali Kimya A.S. Assets
Year Assets Growth
2004 163.733.973
2005 157.998.516 -3.63%
2006 162.451.930 2.74%
2007 163.471.030 0.62%
2008 175.196.124 6.69%
2009 187.621.692 6.62%
2010 213.628.661 12.17%
2011 264.099.395 19.11%
2012 265.527.158 0.54%
2013 273.819.471 3.03%
2014 247.270.551 -10.74%
2015 280.789.281 11.94%
2016 349.489.823 19.66%
2017 390.015.470 10.39%
2018 478.152.897 18.43%
2019 552.759.862 13.5%
2020 754.515.740 26.74%
2021 1.150.223.512 34.4%
2022 1.743.754.744 34.04%
2023 2.125.826.076 17.97%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Alkim Alkali Kimya A.S. Liabilities
Year Liabilities Growth
2004 56.002.518
2005 33.744.709 -65.96%
2006 37.262.220 9.44%
2007 30.938.460 -20.44%
2008 30.070.362 -2.89%
2009 30.025.476 -0.15%
2010 56.517.403 46.87%
2011 91.680.882 38.35%
2012 86.951.088 -5.44%
2013 84.743.004 -2.61%
2014 51.363.833 -64.99%
2015 68.002.380 24.47%
2016 103.974.955 34.6%
2017 102.688.977 -1.25%
2018 129.634.556 20.79%
2019 130.606.631 0.74%
2020 213.052.491 38.7%
2021 413.129.103 48.43%
2022 496.211.882 16.74%
2023 811.992.316 38.89%

Alkim Alkali Kimya A.S. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
19.73
Net Income per Share
3.16
Price to Earning Ratio
11.4x
Price To Sales Ratio
1.82x
POCF Ratio
12.69
PFCF Ratio
18.64
Price to Book Ratio
4.68
EV to Sales
1.68
EV Over EBITDA
6.82
EV to Operating CashFlow
11.68
EV to FreeCashFlow
17.16
Earnings Yield
0.09
FreeCashFlow Yield
0.05
Market Cap
5,40 Bil.
Enterprise Value
4,97 Bil.
Graham Number
23.39
Graham NetNet
2.61

Income Statement Metrics

Net Income per Share
3.16
Income Quality
0.77
ROE
0.43
Return On Assets
0.23
Return On Capital Employed
0.45
Net Income per EBT
0.71
EBT Per Ebit
1.02
Ebit per Revenue
0.23
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.26
Operating Profit Margin
0.23
Pretax Profit Margin
0.24
Net Profit Margin
0.17

Dividends

Dividend Yield
0.03
Dividend Yield %
2.57
Payout Ratio
0.34
Dividend Per Share
0.93

Operating Metrics

Operating Cashflow per Share
2.84
Free CashFlow per Share
1.93
Capex to Operating CashFlow
-0.32
Capex to Revenue
-0.05
Capex to Depreciation
-4.1
Return on Invested Capital
0.45
Return on Tangible Assets
0.22
Days Sales Outstanding
57.82
Days Payables Outstanding
93.37
Days of Inventory on Hand
106.92
Receivables Turnover
6.31
Payables Turnover
3.91
Inventory Turnover
3.41
Capex per Share
-0.91

Balance Sheet

Cash per Share
3,51
Book Value per Share
7,70
Tangible Book Value per Share
8.73
Shareholders Equity per Share
7.7
Interest Debt per Share
0.52
Debt to Equity
0.06
Debt to Assets
0.03
Net Debt to EBITDA
-0.59
Current Ratio
2.22
Tangible Asset Value
1,31 Bil.
Net Current Asset Value
0,84 Bil.
Invested Capital
0.06
Working Capital
0,91 Bil.
Intangibles to Total Assets
0
Average Receivables
0,48 Bil.
Average Payables
0,40 Bil.
Average Inventory
569101407.5
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Alkim Alkali Kimya A.S. Dividends
Year Dividends Growth
2004 372
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 100%
2019 2 50%
2020 2 -100%
2021 1 0%
2022 1 0%
2023 1 0%

Alkim Alkali Kimya A.S. Profile

About Alkim Alkali Kimya A.S.

Alkim Alkali Kimya A.S. produces and sells paper products in Turkey and internationally. It operates through three segments: Chemical Products, Paper, and Other. The company produces and distributes various chemical materials. It offers sodium sulphate for use in detergent, glass, pulp and paper, and textile products, as well as in the production of various chemicals, including potassium sulfate, aluminum sulfate, sodium silicate, and sodium sulphur; salts for use in food, textile, de-icing, leather, chemistry, health, and animal feed industries; leonite fertilizers; and magnesium compounds, such as magnesium chloride and magnesium sulfate. The company also operates chrome mine, which covers an area of 1,200 hectares located in Eskisehir region; produces paper products, such as offset, coated, office, glossy, and photocopy papers, as well as paper pulp; and offers insurance brokerage services, as well as produces and sells electricity and heat energy. Alkim Alkali Kimya A.S. was founded in 1948 and is headquartered in Istanbul, Turkey.

CEO
Mr. Mehmet Reha Kora M.Sc
Employee
724
Address
InOenUe Caddesi No:13
Istanbul, 34437

Alkim Alkali Kimya A.S. Executives & BODs

Alkim Alkali Kimya A.S. Executives & BODs
# Name Age
1 S. Yildiz Pay
Secretary
70
2 Ilhan Kinaci
General Manager
70
3 Çagla Koçel
Investor Relation Department Manager
70
4 Mr. Ferruh Çaliskan
Human Resources Manager
70
5 Hakan Acun
Technical Manager
70
6 Mr. Kerim Oygur
Assistant General Manager of Investment & Finance
70
7 Mr. Adem Haluk Kora M.Sc
Executive Vice Chairman
70
8 Mustafa Güresti
Assistant General Manager of Finance & Accounting
70
9 Sonay Demirer
Assistant General Manager of Sales & Marketing
70
10 Mr. Mehmet Reha Kora M.Sc
Executive Chairman
70

Alkim Alkali Kimya A.S. Competitors